Articles from Spacelabs Healthcare

Spacelabs Healthcare today announced its Rothman Index® predictive analytics platform has been highlighted in an international film featuring advancements that are helping nurses improve care. The film, called “Caring with Courage,” was produced by BBC StoryWorks Commercial Productions and will be presented by the International Council of Nurses at its annual meeting held June 9-13, 2025, in Helsinki, Finland.

Spacelabs Healthcare, a division of OSI Systems, Inc., announces its Rothman Index clinical decision support system has received an Innovative Technology designation for its predictive analytics technology from Vizient, Inc., the largest provider-driven healthcare performance improvement company in the country. Spacelabs Healthcare exhibited the Rothman Index at the Vizient Innovative Technology Exchange October 17 in Dallas.

Today, Snoqualmie Valley Health and Spacelabs Healthcare announced a collaboration to improve access to state-of-the-art patient care in small, rural, or underserved communities. Their shared mission of advancing health equity in every community and every population will be achieved by empowering providers and patients with innovative solutions, reducing barriers, and enabling access to connected care pathways. Snoqualmie Valley Health (SVH), comprised of a 25-bed critical access hospital and several clinics located 30 miles from Seattle, will test Spacelabs monitoring equipment, provide access to the hospital’s care teams, and open its facility to other healthcare systems to experience the equipment in action.

Spacelabs Healthcare today announced that it has acquired predictive analytics company PeraHealth. Founded in 2010, PeraHealth develops predictive enterprise software based on the Rothman Index, a score to quantify patient acuity. PeraHealth’s solutions alert clinicians to patient deterioration, helping to reduce in-hospital mortality, unplanned transfers to the ICU, and to drive more timely palliative care consults. PeraHealth’s Rothman Index is the only FDA-cleared predictive analytics solution of its kind on the market today.

Spacelabs Healthcare, a division of OSI Systems, Inc. (“OSI Systems”), today announced that it will be demonstrating new diagnostic cardiology products at the American College of Cardiology’s (“ACC”) 71st annual event.

Spacelabs Healthcare, a division of OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS), today announced the release of CardioPulse™ Go and CardioPulse™ Prime resting Electrocardiograph (ECG) devices.

Spacelabs Healthcare (the “Company” or “Spacelabs”), a division of OSI Systems, Inc. (“OSI Systems”) (NASDAQ: OSIS), today announced the release of Lifescreen™ Pro event screening system. Lifescreen Pro expands the Company’s non-invasive cardiology offerings, which include Spacelabs Pathfinder SL ambulatory ECG analysis system. Building on 40 years of technology, design, algorithm development and experience in the analysis of ambulatory ECG recordings, the release of Lifescreen Pro continues Spacelabs’ mission to diagnose cardiac arrhythmias accurately and economically.

Spacelabs Healthcare®, a division of OSI Systems, Inc. (the “Company” or “OSI Systems”), and Masimo today announced that they have extended their partnership in patient monitoring to integrate SET® pulse oximetry, NomoLine® capnography, rainbow SET® Pulse CO-Oximetry, SedLine® brain function monitoring, and O3® regional oximetry into select Spacelabs multi-parameter monitors.

Spacelabs Healthcare, a division of OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS), announced today that it has been awarded a three-year Premier agreement for physiological patient monitoring and non-invasive cardiology solutions.